- Home
- PMCB vs CARV Comparison
PMCB vs CARV Comparison
Compare PMCB & CARV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- CARV
- Stock Information
- Founded
- PMCB 1996
- CARV 1948
- Country
- PMCB United States
- CARV United States
- Employees
- PMCB N/A
- CARV N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- CARV Savings Institutions
- Sector
- PMCB Health Care
- CARV Finance
- Exchange
- PMCB Nasdaq
- CARV Nasdaq
- Market Cap
- PMCB 7.3M
- CARV 7.3M
- IPO Year
- PMCB N/A
- CARV 1994
- Fundamental
- Price
- PMCB $1.07
- CARV $1.78
- Analyst Decision
- PMCB
- CARV
- Analyst Count
- PMCB 0
- CARV 0
- Target Price
- PMCB N/A
- CARV N/A
- AVG Volume (30 Days)
- PMCB 11.9K
- CARV 35.1K
- Earning Date
- PMCB 08-12-2025
- CARV 08-13-2025
- Dividend Yield
- PMCB N/A
- CARV N/A
- EPS Growth
- PMCB N/A
- CARV N/A
- EPS
- PMCB 1.29
- CARV N/A
- Revenue
- PMCB N/A
- CARV $21,046,000.00
- Revenue This Year
- PMCB N/A
- CARV N/A
- Revenue Next Year
- PMCB N/A
- CARV N/A
- P/E Ratio
- PMCB $0.86
- CARV N/A
- Revenue Growth
- PMCB N/A
- CARV N/A
- 52 Week Low
- PMCB $1.00
- CARV $1.30
- 52 Week High
- PMCB $2.42
- CARV $2.20
- Technical
- Relative Strength Index (RSI)
- PMCB 48.32
- CARV 60.34
- Support Level
- PMCB $1.06
- CARV $1.63
- Resistance Level
- PMCB $1.15
- CARV $1.83
- Average True Range (ATR)
- PMCB 0.05
- CARV 0.15
- MACD
- PMCB 0.01
- CARV 0.00
- Stochastic Oscillator
- PMCB 45.47
- CARV 84.24
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About CARV Carver Bancorp Inc.
Carver Bancorp Inc is a holding company and conducts its business as a unitary saving and loan holding firm and the business of the company consists of the operation of its subsidiary. The bank offers a wide range of financial solutions to meet customers' banking. It offers other consumer and commercial banking products and services, such as debit cards, online banking, online bill pay, and telephone banking. The company provides deposit products, such as demand, savings, and time deposits for consumers, businesses, and governmental and quasi-governmental agencies in its market area within New York City.